TNFSF13 and immunoglobulin G4-related sclerosing disease: Similar results have been reported in systemic lupus erythematosus (SLE) and IgG4-related diseases, emphasizing the potential of plasmablast surveillance to evaluate disease activity, which may be linked to BLyS and APRIL levels (50–53).